TUBERCULOSIS WITH MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT OF MICOBACTERIUM TUBERCULOSIS IN THE RUSSIAN FEDERATION

TUBERCULOSIS WITH MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT OF MICOBACTERIUM TUBERCULOSIS IN THE RUSSIAN FEDERATION

Objective: To assess the epidemic situation in the Russian Federation on tuberculosis with multidrug-resistant and extensively drug-resistant (MDR, XDR) of the pathogen and the effectiveness of its treatment. Methods: The information on forms of official statistical observation of the Russian Fed...

Full description

Bibliographic Details
Main Authors:	A.E. ERGESHOV, V.V. PUNGA, L.I. RUSAKOVA, S.A. STERLIKOV, M.A. YAKIMOVA, Т.V. IZMAYLOVA
Format:	Article
Language:	English
Published:	Avicenna Tajik State Medical University 2018-08-01
Series:	Паёми Сино
Subjects:	tuberculosis multiple drug resistance extensively drug resistance treatment outcomes.
Online Access:	https://doi.org/10.25005/2074-0581-2018-20-2-3-314-319

Similar Items

Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis
by: Getu Diriba, et al.
Published: (2023-07-01)

Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains in geriatrics: An analysis and its implications in tuberculosis control
by: Ajoy Kumar Verma, et al.
Published: (2022-05-01)

Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives
by: Singh A, et al.
Published: (2020-01-01)

EXTENSIVELY DRUG RESISTANT TUBERCULOSIS (XDR TB)
by: Sarah Rahmayani Siregar
Published: (2019-12-01)

Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China
by: Kefyalew Addis Alene, et al.
Published: (2017-08-01)

Bedaquiline in the multidrug-resistant tuberculosis treatment: Belarus experience
by: Alena Skrahina, et al.
Published: (2016-01-01)

The longitudinal trends of multidrug and extensively drug resistant tuberculosis in China
by: Yi Hu, et al.
Published: (2015-01-01)

Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies
by: R Prasad
Published: (2012-01-01)

Multidrug-Resistant Tuberculosis in Europe, 2010–2011
by: Gunar Günther, et al.
Published: (2015-03-01)

Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid
by: Francesco Pecora, et al.
Published: (2021-05-01)

Multidrug-resistant tuberculosis in Lithuania – Still a long way ahead
by: Greta Musteikienė, et al.
Published: (2016-01-01)

Programmatic challenges in managing multidrug-resistant tuberculosis in Malawi
by: Loveness Charlie, et al.
Published: (2021-01-01)

Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis
by: N. Yu. Nikolenko, et al.
Published: (2021-07-01)

Extensively Drug-resistant Tuberculosis, Italy and Germany
by: Giovannittista Migliori, et al.
Published: (2007-05-01)

Pathogenesis of multi drug-resistant and extensively drug-resistant tuberculosis as a determinant of future treatment success
by: Faramarz Valafar
Published: (2016-01-01)

First and Second-Line Anti-Tuberculosis Drug-Resistance Patterns in Pulmonary Tuberculosis Patients in Zambia
by: Ngula Monde, et al.
Published: (2023-01-01)

Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis
by: Lawrence Mbuagbaw, et al.
Published: (2019-05-01)

ANTITUBERCULOSIS DRUG ALLERGY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS
by: B.B. MAYKANAEV, et al.
Published: (2021-06-01)

Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa
by: Navisha Dookie, et al.
Published: (2016-10-01)

Increasing Drug Resistance in Extensively Drug-Resistant Tuberculosis, South Africa
by: N. Sarita Shah, et al.
Published: (2011-03-01)

Detection of multidrug resistance and extensively drug resistance among smear-negative extrapulmonary tuberculosis cases in a reference laboratory
by: Srashty Sharma, et al.
Published: (2018-01-01)

Efficacy of Tuberculosis Treatment in Patients with Drug-Resistant Tuberculosis with the Use of Bedaquiline: The Experience of the Russian Federation
by: Anna Starshinova, et al.
Published: (2022-11-01)

Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis
by: Shynar M. Maretbayeva, et al.
Published: (2021-12-01)

A cross-sectional study about knowledge and attitudes toward multidrug-resistant and extensively drug-resistant tuberculosis in a high-burden drug-resistant country
by: Hasnain Javed, et al.
Published: (2016-01-01)

Extensively Drug-Resistant Tuberculosis, China
by: Shenjie Tang, et al.
Published: (2011-03-01)

Obstacles in combating multidrug resistant tuberculosis in pediatric patients: a scope review
by: Letícia Baltar Sobreira, et al.
Published: (2024-01-01)

The spectrum of primary drug resistance of Mycobacterium tuberculosis in patients with tuberculosis in relation to human immunodeficiency virus status
by: V N Zimina, et al.
Published: (2017-11-01)

Frequency of mutations associated with resistance to first- and second-line drugs in multidrug-resistant Mycobacterium tuberculosis isolates
by: Ibrahim Bitar, et al.
Published: (2020-09-01)

SHORT-TERM CHEMOTHERAPY REGIMEN OF MULTIDRUG-RESISTANT TUBERCULOSIS IN THE KYRGYZ REPUBLIC
by: E.V. ZHDANOVA, et al.
Published: (2018-08-01)

Overview of drug-resistant tuberculosis worldwide
by: Ali A Velayati, et al.
Published: (2016-01-01)

Knowledge, attitude, and practices of health-care providers toward antibiotic prescribing, antibiotic resistance, and multidrug-resistant tuberculosis
by: Ashna Malhotra, et al.
Published: (2021-01-01)

A Case of Disseminated Extensively Drug Resistant Extrapulmonary Tuberculosis
by: Diti V Gandhasiri, et al.
Published: (2020-11-01)

Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis
by: А. V. Kukurika
Published: (2022-10-01)

Pyrosequencing for diagnosis of multidrug and extensively drug-resistant tuberculosis: A systemic review and meta-analysis
by: Emnet Getachew, et al.
Published: (2021-08-01)

Predictors of time to sputum culture conversion in multi-drug-resistant tuberculosis and extensively drug-resistant tuberculosis in patients at Tshepong-Klerksdorp Hospital
by: Relebohile Ncha, et al.
Published: (2019-08-01)

Extensively-drug resistant tuberculosis: A new strain and future challenge
by: Ratikorn Gamngoen, et al.
Published: (2015-01-01)

Adverse treatment outcomes in multidrug resistant tuberculosis go beyond the microbe-drug interaction: Results of a multiple correspondence analysis.
by: Ángela Tobón, et al.
Published: (2020-12-01)

GENOTYPES OF EXTENSIVELY DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS STRAINS: CLINICAL AND EPIDEMIOLOGICAL FEATURES OF PULMONARY TUBERCULOSIS
by: N. R. Vasilieva, et al.
Published: (2016-06-01)

Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China
by: Li Y, et al.
Published: (2019-03-01)

The Characteristics and Patterns of Drug-Resistant Pulmonary Tuberculosis in Eastern India
by: Vishal Prakash Giri, et al.
Published: (2022-09-01)